Find a partnership program with SOM Biotech that’s right for you
Pipeline expansion within any therapeutic area
Life cycle management of existing products to expand opportunities on the market
New targets identification for your shelved assets
Indication expansion for your assets in development
In-licensing of our advanced assets
Co-development, or in-licensing, of our early-stage assets
We use a unique approach based on our Artificial Intelligence based technology SOMAI PRO and the expertise of our Team and Key Opinion Leaders.
Learn about our Approach
Our pipeline
2 products successfully completed clinical Phase 2a and received FDA Orphan Drug Designation
5 products in Clinical Development
4 products in Preclinical Development
Learn about our Pipeline
OUR SUCCESSFUL DEALS
We have completed 2 out-licensing deals
Read our news
Our Partners
We partner with Pharmaceutical and biotech companies and academic and research institutions from across the world
Learn about our partners
Some of our programs were funded by the Public Grants.
